Literature DB >> 31113473

How to treat combined respiratory and metabolic acidosis after extracorporeal cardiopulmonary resuscitation?

Xavier Bemtgen1, Florentine Schroth2, Tobias Wengenmayer2, Paul M Biever2, Daniel Duerschmied2, Christoph Benk3, Christoph Bode2, Dawid L Staudacher2.   

Abstract

Entities:  

Keywords:  Carbon dioxide; Survival; VA-ECMO; eCPR; pH; paCO2

Mesh:

Substances:

Year:  2019        PMID: 31113473      PMCID: PMC6530035          DOI: 10.1186/s13054-019-2461-2

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
Establishing a venoarterial extracorporeal membrane oxygenation (vaECMO) in cardiac arrest is known as extracorporeal cardiopulmonary resuscitation (eCPR). After eCPR, patients commonly present with a combined respiratory and metabolic acidosis [1]. It is clear that acidosis negatively impacts survival after eCPR [2] and that a respiratory acidosis can be easily corrected by vaECMO. Current guidelines for conventional CPR suggest normocapnia as targeted after return of spontaneous circulation [3]. This recommendation is based on heterogeneous data. While a recent meta-analysis found adverse outcome in both hyper- and hypocapnia [4], a randomized trial reported no difference in survival in low normal and high normal paCO2 [5]. The aim of the present study was to correlate arterial paCO2 and pH with hospital survival in eCPR. A single-center retrospective register analysis was performed. All eCPR patients treated between 2010 and 2017 were included. We analyzed arterial blood gases after 1 h, 3 h, 6 h, 12 h, and 24 h as well as hospital mortality. We detected a total of 186 eCPR. The mean age was 58.6 ± 14.9 years, and total hospital survival rate was 26.3%. After cannulation, paCO2 and pH values were (mean ± standard deviation) 38.3 ± 8.9 mmHg/7.28 ± 0.14 (+ 1 h), 38.5 ± 8.5 mmHg/7.30 ± 0.11 (+ 3 h), 38.72 ± 7.42 mmHg/7.31 ± 0.11 (+ 6 h), 38.62 ± 7.26 mmHg/7.34 ± 0.10 (+ 12 h), and 38.22 ± 5.62 mmHg/7.38 ± 0.09 (+ 24 h), respectively. When comparing patients with paCO2 < 35, 35–45, and > 45 mmHg, survival was statistically similar for all observed time points. There was however a highly significant association between hospital survival and pH when comparing groups with pH < 7.3, 7.3–7.4, and > 7.4 (see Fig. 1).
Fig. 1

Survival of eCPR patients according to pH and paCO2 values at different time points. No significant correlation of survival and paCO2 level could be detected at any analyzed time point whereas pH was highly correlated with survival (a, c, chi-square shown in graph). b, d Example Kaplan-Meier survival curves according to paCO2 and pH 6 h after eCPR (log-rank tests shown in graph)

Survival of eCPR patients according to pH and paCO2 values at different time points. No significant correlation of survival and paCO2 level could be detected at any analyzed time point whereas pH was highly correlated with survival (a, c, chi-square shown in graph). b, d Example Kaplan-Meier survival curves according to paCO2 and pH 6 h after eCPR (log-rank tests shown in graph) As secondary endpoint and surrogate for neurological outcome, neuron-specific enolase (NSE) was analyzed. Maximum NSE measured within 72 h after eCPR was 150.8 ± 145.1 μg/l (mean ± standard deviation). When correlating maximum NSE with paCO2 at 1, 3, 6, 12, and 24 h after eCPR, no statistical significant linear correlation was found (p > 0.4 for all time points). There was however a significant linear correlation of maximum NSE and pH at 1, 3, and 6 h after eCPR (p = 0.037, 0.029, and 0.018, respectively). In this registry study, we found a strong correlation between hospital survival and arterial pH but no such correlation with paCO2. Also elevated NSE as a marker for neural injury did correlate with pH but not with paCO2. Being a retrospective, observational, single-center study, inherent limitations and biases are to be presumed and findings are to be considered hypothesis generating. Until further data are available however, it might be reasonable to correct both respiratory and metabolic acidosis in eCPR patients.
  2 in total

1.  Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience.

Authors:  Viviane Zotzmann; Jonathan Rilinger; Corinna N Lang; Klaus Kaier; Christoph Benk; Daniel Duerschmied; Paul M Biever; Christoph Bode; Tobias Wengenmayer; Dawid L Staudacher
Journal:  Crit Care       Date:  2019-09-18       Impact factor: 9.097

2.  Initial Arterial pCO2 and Its Course in the First Hours of Extracorporeal Cardiopulmonary Resuscitation Show No Association with Recovery of Consciousness in Humans: A Single-Centre Retrospective Study.

Authors:  Loes Mandigers; Corstiaan A den Uil; Jeroen J H Bunge; Diederik Gommers; Dinis Dos Reis Miranda
Journal:  Membranes (Basel)       Date:  2021-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.